Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03698942 · ClinicalTrials.gov registry record
Delphinus SoftVue™ ROC Reader Study
A clinical trial, sponsored by Delphinus Medical Technologies.
- Completed
- Registry status
- 6
- Enrollment target
NCT03698942 is a clinical trial that has completed, run by Delphinus Medical Technologies. The registered enrollment target is 6 participants.
The verdict
NCT03698942 has completed, sponsored by Delphinus Medical Technologies.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The purpose of this multi-reader, multi-case (MRMC) reader study is to evaluate reader performance when SoftVue™ automated breast ultrasound and screening mammography are combined, compared to screening mammography alone, in women with dense breast parenchyma. This includes obtaining information that can be used to properly plan, design, and power future ROC reader studies. This reader study will include a minimum of 6 radiologist readers and an enriched sample of at least 100 breast screening or diagnostic cases to be selected from the library of images collected under Delphinus Protocol #DMT-2015.001 (NCT03257839). The reader study image case set will be enriched with cancer cases.
Interventions
- DEVICE Reading of Automated Breast Ultrasound in conjunction with Screening Mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-09-23 |
| Est. Completion | 2018-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03698942
The ClinicalTrials.gov registry entry for NCT03698942 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Delphinus Medical Technologies, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reading of Automated Breast Ultrasound in conjunction with Screening Mammography is the first listed.
NCT03698942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03698942 about?
NCT03698942 is a clinical study titled "Delphinus SoftVue™ ROC Reader Study". The purpose of this multi-reader, multi-case (MRMC) reader study is to evaluate reader performance when SoftVue™ automated breast ultrasound and screening mammography are combined, compared to screening mammography alone, in women with dense breast parenchyma. This includes obtaining information tha...
What is the current status of trial NCT03698942?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2018-09-23. Estimated completion is 2018-09-23.
What interventions are being tested in trial NCT03698942?
The interventions under investigation include: Reading of Automated Breast Ultrasound in conjunction with Screening Mammography (DEVICE).
Who is sponsoring clinical trial NCT03698942?
This trial is sponsored by Delphinus Medical Technologies, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.